In our study, however, treatment with recombinant POSTN neither resulted in stabilization of the MAPK pathway nor increased survival of melanoma cells upon MEKi treatment, suggesting that POSTN plays an indirect effect on resistance formation. This evidence concerns the gene POSTN and melanoma.